Last updated at 21 Jul 2024 10:56 PM
Director
DIN: 08157479
Geeta Prashant Chaudhari is currently associated with 2 companies in various capacities such as Additional Director and Director. They serve as a Director at PRIME PATHOLOGY AND RESEARCH CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08157479.Geeta Prashant Chaudhari is currently involved in 2 different roles. Their most recent position is with BIOLIMA HEALTHCARE PRIVATE LIMITED as a Director. The first company Geeta Prashant Chaudhari was appointed to as a director was PRIME PATHOLOGY AND RESEARCH CENTRE PRIVATE LIMITED. Geeta Prashant Chaudhari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Geeta Prashant Chaudhari is currently associated with 2 companies in various capacities such as Additional Director and Director. They serve as a Director at PRIME PATHOLOGY AND RESEARCH CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08157479.Geeta Prashant Chaudhari is currently involved in 2 different roles. Their most recent position is with BIOLIMA HEALTHCARE PRIVATE LIMITED as a Director. The first company Geeta Prashant Chaudhari was appointed to as a director was PRIME PATHOLOGY AND RESEARCH CENTRE PRIVATE LIMITED. Geeta Prashant Chaudhari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PRIME PATHOLOGY AND RESEARCH CENTRE PRIVATE LIMITED | Additional Director | 22-Sep-2018 |
| BIOLIMA HEALTHCARE PRIVATE LIMITED | Director | 31-Jan-2024 |